Why Is Kenalog So Hard to Find? [Explained for 2026]

If you or a family member has been prescribed Kenalog (triamcinolone acetonide) and your pharmacy says it's out of stock, you're not alone. In 2026, Kenalog is experiencing an active, multi-manufacturer shortage that is affecting patients across the United States. This article explains why Kenalog is so hard to find, which manufacturers are impacted, and what steps you can take right now.

What Is Kenalog and Why Do So Many People Need It?

Kenalog is a brand name for triamcinolone acetonide, a long-acting corticosteroid injection. It has been FDA-approved since 1965 and is used by millions of Americans to treat a wide range of inflammatory conditions, including rheumatoid arthritis, osteoarthritis, gout, allergic reactions, asthma flares, eczema, bursitis, tendinitis, and even multiple sclerosis. Because it can be injected directly into a joint, muscle, or skin lesion, it provides targeted, long-lasting relief — often for several weeks from a single dose.

Kenalog comes in three main strengths: Kenalog-10 (10 mg/mL, for joint and intralesional injections), Kenalog-40 (40 mg/mL, for intramuscular and intra-articular use), and Kenalog-80 (80 mg/mL, for larger-dose IM injections). The generic form, triamcinolone acetonide, is available for the 40 mg/mL strength. It's widely used in rheumatology, orthopedics, dermatology, and primary care offices. When it's unavailable, patients with painful joints or chronic inflammatory conditions can be left without a critical treatment option.

Is Kenalog Actually in Shortage in 2026?

Yes. The American Society of Health-System Pharmacists (ASHP) confirms that triamcinolone acetonide injectable suspension is in active shortage as of 2025–2026. Multiple manufacturers are simultaneously affected, which is what makes this shortage especially disruptive. Here's a breakdown of where each manufacturer stands:

Eugia US: Discontinued their triamcinolone acetonide 40 mg/mL formulations entirely in mid-2025.

Hikma: Has 40 mg/mL 1 mL vials on allocation only — available exclusively to contracted customers.

Long Grove Pharmaceuticals: 5 mL and 10 mL vials on intermittent back order; releasing product as it becomes available.

Viatris (Mylan): 5 mL and 10 mL vials on back order; estimated release date late-June 2026.

Teva: In shortage; no reason provided.

Amneal: Has product on allocation to contracted customers only.

Bristol-Myers Squibb (brand Kenalog): Has not provided a reason for the shortage of brand Kenalog injectable suspension; some presentations remain available.

Why Is There a Kenalog Shortage?

While manufacturers have not all disclosed their specific reasons, the Kenalog shortage reflects broader structural problems in the generic injectable drug market. Sterile injectable medications like triamcinolone are expensive to manufacture, require specialized facilities, and have thin profit margins. This creates a fragile supply chain where even one manufacturing disruption can ripple across the entire market.

Key contributing factors include:

Manufacturer consolidation: A small number of companies produce most of the generic injectable triamcinolone supply. When even one drops out (as Eugia did in 2025), remaining suppliers face overwhelming demand.

Increased demand: Long Grove has cited increased demand as a reason for its shortage. The growing number of Americans managing arthritis, autoimmune disease, and chronic pain has increased baseline demand for injectables.

Good manufacturing practice (GMP) compliance issues: Some manufacturers have faced FDA manufacturing compliance requirements that slow or halt production.

Supply chain vulnerabilities: Active pharmaceutical ingredient (API) sourcing and packaging supply chains for sterile injectables remain fragile post-pandemic.

Which Pharmacies Are Most Likely to Have Kenalog in Stock?

Kenalog and generic triamcinolone acetonide injection are primarily stocked and dispensed in medical offices and outpatient clinics, not traditional retail pharmacies. However, some compounding pharmacies, specialty pharmacies, and hospital outpatient pharmacies may carry vials for administration. Because supply is on allocation at several manufacturers, access depends heavily on which distributor or GPO (Group Purchasing Organization) your clinic or pharmacy has contracts with.

During a shortage, availability can vary dramatically from one pharmacy to another — even in the same city. Calling ahead is essential, but it's time-consuming and frustrating. That's where medfinder can help.

How medfinder Can Help You Find Kenalog

Instead of calling every pharmacy in your area yourself, medfinder does it for you. You provide your medication, dosage, and location — and medfinder calls pharmacies near you to find out which ones can fill your prescription. Results are texted directly to you so you can get to the right pharmacy the first time.

What Are the Alternatives if Kenalog Is Unavailable?

If you or your provider cannot locate Kenalog or generic triamcinolone acetonide injection, several alternatives may be considered depending on your condition:

Depo-Medrol (methylprednisolone acetate): The most widely used alternative for joint injections; equally potent to Kenalog, does not contain benzyl alcohol, and is generally available.

Celestone Soluspan (betamethasone): A long-acting injectable corticosteroid used as an alternative for joint and soft tissue injections.

Dexamethasone: A non-particulate corticosteroid preferred for certain injection routes (e.g., around sensitive structures), though shorter-acting.

Always discuss any switch with your prescriber — they can determine which alternative is most appropriate for your specific condition and injection site. For a deeper dive, see our guide to alternatives to Kenalog.

What Should You Do Right Now?

If your pharmacy says Kenalog is out of stock, take these steps:

Contact your prescriber immediately. Let them know the pharmacy can't fill the order so they can explore alternatives or suggest another pharmacy.

Use medfinder to check availability at pharmacies near you without making dozens of calls yourself.

Ask your prescriber about therapeutic alternatives such as Depo-Medrol if Kenalog remains unavailable.

Check with specialty or hospital outpatient pharmacies, which may have access to allocation stock not available at retail chains.

For the latest shortage status, see our Kenalog shortage update for 2026.